Deloitte Legal (formerly Laga) assists MRM Health with a series A investment round by several investors

Deloitte Legal assisted MRM Health NV, a biopharmaceutical company focused on the discovery and development of innovative therapeutics based on the human microbiome, with a EUR 14 Million series A investment round by Ackermans & van Haaren, DuPont Nutrition & Biosciences, MRM Technologies, Qbic II and VIB.

Christoph Michiels and Jan De Poorter from the Corporate and M&A practice, together with Matthias Vierstraete from the Intellectual Property practice, comprised the team assisting in this transaction.

Read more in the press release issued by MRM Health